Third-party tested for 99% purity
NAD+ [500mg]
Original price was: ₹190.00.₹95.00Current price is: ₹95.00.
50% OFF
62 in stock
Product Description
NAD+ (Nicotinamide Adenine Dinucleotide) is a chemical compound commonly referenced in biochemical and molecular research settings. It is supplied in a lyophilized form to support stability during storage and transport and is intended strictly for controlled laboratory research applications.
You may also like…
Description
NAD+ [500mg]
Research Use Only. Not for human or animal consumption. Not for use in diagnostic or therapeutic procedures. These products are not FDA-approved to diagnose, treat, cure, or prevent any disease.
Product Description
NAD+ (Nicotinamide Adenine Dinucleotide) is a chemical compound commonly referenced in biochemical and molecular research settings. It is supplied in a lyophilized form to support stability during storage and transport and is intended strictly for controlled laboratory research applications.
![NAD+ <span>[500mg]</span>](https://elixserpeptidesnew.getkgkrunch.com/wp-content/uploads/2026/04/13_0198e476-d951-4b62-89f4-37dc5a02551c.webp)
![NAD+ <span>[500mg]</span> - Image 2](https://elixserpeptidesnew.getkgkrunch.com/wp-content/uploads/2026/04/NAD.webp)
![MOTS-C <span>[10mg]</span>](https://elixserpeptidesnew.getkgkrunch.com/wp-content/uploads/2026/04/12_a4f2019b-3361-4047-a966-643c8c8f4711-300x375.webp)
![SS-31 [30mg]](https://elixserpeptidesnew.getkgkrunch.com/wp-content/uploads/2026/04/NEW_-_Elixser_Labs_-_Cards_with_Vials_16-300x375.webp)
![THYMULIN <span>[20mg]</span>](https://elixserpeptidesnew.getkgkrunch.com/wp-content/uploads/2026/04/THYMULIN-1-300x375.png)
![SS-31 [10mg]](https://elixserpeptidesnew.getkgkrunch.com/wp-content/uploads/2026/04/NEW_-_Elixser_Labs_-_Cards_with_Vials_3-300x375.webp)
![TESAMORELIN + IPAMORELIN <span>[10mg]</span>](https://elixserpeptidesnew.getkgkrunch.com/wp-content/uploads/2026/04/NEW-ElixserLabs-CardswithVials_4_37a8dec0-3f71-4de0-b172-29902c476ee8-300x375.webp)

Reviews
There are no reviews yet.